Skip to main content
OpenTrials

Clinical trial condition

Paraproteinemias

Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.

3,004 public trials 571 recruiting studies
Refine in advanced search Browse all conditions

Paraproteinemias trial results

Completed

Multinational Clinical Study Comparing Isatuximab, Carfilzomib And Dexamethasone To Carfilzomib And Dexamethasone In Relapse And/Or Refractory Multiple Myeloma Patients

NCT03275285

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • UCSF MS Center Site Number : 8400002 San Francisco, California, United States
  • Spartanburg Medical Center Site Number : 8400003 Spartanburg, South Carolina, United States
  • Investigational Site Number : 0360005 Blacktown, New South Wales, Australia
  • Investigational Site Number : 0360006 Tweed Heads, New South Wales, Australia
View all 70 locations
View Trial Details
Completed

A Study of CC-95266 in Participants With Relapsed and/or Refractory Multiple Myeloma

NCT04674813

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Local Institution - 005 Birmingham, Alabama, United States
  • Local Institution - 009 Duarte, California, United States
  • Local Institution - 012 San Francisco, California, United States
  • Local Institution - 002 Denver, Colorado, United States
View Trial Details
Completed

Imaging in MGUS, SMM and MM

NCT01237054

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations
  • National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
View Trial Details
Completed

Dose-Escalation Study of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM)

NCT03275103

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Hospital - Arizona Scottsdale, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of Colorado Denver Aurora, Colorado, United States
View all 17 locations
View Trial Details
Completed

Zanubrutinib (BGB-3111) in Participants With Previously Treated B-Cell Lymphoma Intolerant of Prior Bruton Tyrosine Kinase Inhibitor (BTKi) Treatment

NCT04116437

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +29 more
Locations
  • Rocky Mountain Cancer Centers (Williams) Usor Aurora, Colorado, United States
  • Christiana Care Newark, Delaware, United States
  • Scri Florida Cancer Specialists South Fort Myers, Florida, United States
  • St Century Oncology Jacksonville, Florida, United States
View all 24 locations
View Trial Details
Completed

A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL

NCT03740529

Conditions
B-cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +35 more
Locations
  • Mayo Clinic of Scottsdale Scottsdale, Arizona, United States
  • Scripps Coastal Medical Center San Diego, California, United States
  • University of California San Francisco, Medical Center at Paranassus San Francisco, California, United States
  • Smilow Cancer Hospital at Yale-New Haven New Haven, Connecticut, United States
View all 56 locations
View Trial Details

Related conditions